Assignee
DYAX CORP
US·120 granted patents·63 pending applications·4,623 citations·filing 1994–2020
Top patents by PatentIndex Score
183 records- 0198US7851442B2Prevention and reduction of blood lossDYAX CORP·Filed 2007·Granted Dec 14, 2010·46 cites·14 claims
- 0298US7811991B2Prevention and reduction of blood lossDYAX CORP·Filed 2007·Granted Oct 12, 2010·48 cites·15 claims
- 0398US7235530B2Kallikrein inhibitors and anti-thrombolytic agents and uses thereofDYAX CORP·Filed 2005·Granted Jun 26, 2007·103 cites·21 claims
- 0498US6423498B1Variegated Kunitz domain peptide library and uses thereofDYAX CORP·Filed 2000·Granted Jul 23, 2002·143 cites·4 claims
- 0597US10370453B2Plasma kallikrein binding proteinsDYAX CORP·Filed 2015·Granted Aug 6, 2019·25 cites·9 claims
- 0697US9034601B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2013·Granted May 19, 2015·26 cites·25 claims
- 0797US8044175B2Peptides that specifically bind HGF receptor (CMET) and uses thereofDYAX CORP·Filed 2008·Granted Oct 25, 2011·44 cites·4 claims
- 0897US7919462B2Inhibitors of human plasmin derived from the Kunitz domainsDYAX CORP·Filed 2007·Granted Apr 5, 2011·29 cites·14 claims
- 0997US7628983B2Kallikrein-binding “Kunitz domain” proteins and analogues thereofDYAX CORP·Filed 2006·Granted Dec 8, 2009·48 cites·13 claims
- 1097US7276480B1Prevention and reduction of blood lossDYAX CORP·Filed 2005·Granted Oct 2, 2007·76 cites·4 claims
- 1197US5837500ADirected evolution of novel binding proteinsDYAX CORP·Filed 1995·Granted Nov 17, 1998·595 cites·43 claims
- 1297US5663143AEngineered human-derived kunitz domains that inhibit human neutrophil elastaseDYAX CORP·Filed 1994·Granted Sep 2, 1997·272 cites·9 claims
- 1396US10059936B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2016·Granted Aug 28, 2018·7 cites·16 claims
- 1496US9556428B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2015·Granted Jan 31, 2017·8 cites·40 claims
- 1596US7064107B2Prevention and reduction of blood lossDYAX CORP·Filed 2003·Granted Jun 20, 2006·86 cites·8 claims
- 1696US6071723AInhibitors of human plasmin derived from the Kunitz domainsDYAX CORP·Filed 1999·Granted Jun 6, 2000·78 cites·20 claims
- 1796US6057287AKallikrein-binding "Kunitz domain" proteins and analogues thereofDYAX CORP·Filed 1994·Granted May 2, 2000·125 cites·8 claims
- 1895US11046785B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2019·Granted Jun 29, 2021·11 cites·7 claims
- 1995US10648990B2Diagnosis and treatment of autoimmune diseasesDYAX CORP·Filed 2018·Granted May 12, 2020·7 cites·10 claims
- 2095US9266964B2Method of treating hereditary angioedema using plasma kallikrein binding antibodiesDYAX CORP·Filed 2014·Granted Feb 23, 2016·24 cites·6 claims
- 2195US9260520B2Antibodies to FeRn and uses thereofDYAX CORP·Filed 2014·Granted Feb 16, 2016·18 cites·6 claims
- 2295US8034775B2Kallikrein-inhibitor therapiesDYAX CORP·Filed 2007·Granted Oct 11, 2011·25 cites·15 claims
- 2395US7485297B2Method of inhibition of vascular development using an antibodyDYAX CORP·Filed 2005·Granted Feb 3, 2009·35 cites·30 claims
- 2495US7208293B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2001·Granted Apr 24, 2007·94 cites·13 claims
- 2595US7118879B2Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target materialDYAX CORP·Filed 2002·Granted Oct 10, 2006·80 cites·26 claims
- 2695US6989369B2Kunitz domain peptidesDYAX CORP·Filed 2003·Granted Jan 24, 2006·53 cites·27 claims
- 2795US6333402B1Kallikrein-binding “Kunitz domain” proteins and analogues thereofDYAX CORP·Filed 1999·Granted Dec 25, 2001·115 cites·7 claims
- 2895US6010880AInhibitors of human plasmin derived from the kunitz domainsDYAX CORP·Filed 1995·Granted Jan 4, 2000·102 cites·16 claims
- 2995US5994125AKallikrein-inhibiting "Kunitz Domain" proteins and analogues thereofDYAX CORP·Filed 1998·Granted Nov 30, 1999·112 cites·7 claims
- 3095US5795865AKallikrein-inhibiting "kunitz domain" proteins and analogues thereofDYAX CORP·Filed 1995·Granted Aug 18, 1998·145 cites·13 claims
- 3194US7704949B2Kallikrein-inhibitor therapiesDYAX CORP·Filed 2006·Granted Apr 27, 2010·33 cites·16 claims
- 3294US7329737B2Antibodies that bind hK-1DYAX CORP·Filed 2005·Granted Feb 12, 2008·54 cites·17 claims
- 3394US7261876B2Multivalent constructs for therapeutic and diagnostic applicationsDYAX CORP·Filed 2003·Granted Aug 28, 2007·33 cites·33 claims
- 3494US7211240B2Multivalent constructs for therapeutic and diagnostic applicationsDYAX CORP·Filed 2003·Granted May 1, 2007·52 cites·67 claims
- 3594US7153829B2Kallikrein-inhibitor therapiesDYAX CORP·Filed 2004·Granted Dec 26, 2006·62 cites·18 claims
- 3694US6979538B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2001·Granted Dec 27, 2005·80 cites·19 claims
- 3794US6103499AInhibitors of human plasmin derived from the Kunitz domainsDYAX CORP·Filed 1999·Granted Aug 15, 2000·79 cites·16 claims
- 3893US10577599B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2018·Granted Mar 3, 2020·3 cites·12 claims
- 3993US10336832B2Methods of inhibiting plasma kallikrein in edema patientDYAX CORP·Filed 2014·Granted Jul 2, 2019·13 cites·7 claims
- 4093US7893007B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2008·Granted Feb 22, 2011·22 cites·19 claims
- 4193US7718617B2Methods for preserving organs and tissuesDYAX CORP·Filed 2007·Granted May 18, 2010·43 cites·9 claims
- 4293US7550427B2Poly-pegylated protease inhibitorsDYAX CORP·Filed 2006·Granted Jun 23, 2009·31 cites·48 claims
- 4393US7413537B2Directed evolution of disulfide-bonded micro-proteinsDYAX CORP·Filed 2002·Granted Aug 19, 2008·40 cites·34 claims
- 4493US7244592B2Ligand screening and discoveryDYAX CORP·Filed 2003·Granted Jul 17, 2007·64 cites·15 claims
- 4593US6984373B2Fibrin binding moieties useful as imaging agentsDYAX CORP·Filed 2001·Granted Jan 10, 2006·57 cites·59 claims
- 4692US10914747B2Immunoassay to detect cleaved high molecular weight kininogenDYAX CORP·Filed 2016·Granted Feb 9, 2021·6 cites·50 claims
- 4792US10428158B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2015·Granted Oct 1, 2019·14 cites·9 claims
- 4892US7166576B2Methods for preserving organs and tissuesDYAX CORP·Filed 2003·Granted Jan 23, 2007·72 cites·3 claims
- 4992US6953674B2Inhibitors of human plasmin derived from the kunitz domainsDYAX CORP·Filed 2002·Granted Oct 11, 2005·31 cites·56 claims
- 5091US9862768B2Methods of producing antibodies to neonatal Fc receptor (FcRn)DYAX CORP·Filed 2016·Granted Jan 9, 2018·7 cites·12 claims
Showing the top 50 of 183 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when DYAX CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →